PharmaCorp Rx (TSXV:PCRX) Inventories, Raw Materials & Components: C$0.06 Mil (As of Mar. 2026)


TSXV:PCRX PharmaCorp Rx Inc TSXV:PCRX
35 GF Score
Price C$0.50
! 2 Warning Signs
View Full Analysis

What is PharmaCorp Rx Inventories, Raw Materials & Components?

PharmaCorp Rx TSXV:PCRX 35 Inventories, Raw Materials & Components is C$0.06 Mil as of Mar. 2026. GuruFocus rates TSXV:PCRX with a GF Score™ of 35/100. The stock has 2 warning signs investors should review.

PharmaCorp Rx's inventories, raw materials & components for the quarter that ended in Mar. 2026 was C$0.06 Mil.

PharmaCorp Rx's quarterly raw materials declined from Sep. 2025 (C$0.05 Mil) to Dec. 2025 (C$0.05 Mil) but then increased from Dec. 2025 (C$0.05 Mil) to Mar. 2026 (C$0.06 Mil).

PharmaCorp Rx's annual raw materials increased from Dec. 2023 (C$0.00 Mil) to Dec. 2024 (C$0.04 Mil) and increased from Dec. 2024 (C$0.04 Mil) to Dec. 2025 (C$0.05 Mil).

PharmaCorp Rx Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for PharmaCorp Rx's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaCorp Rx Inventories, Raw Materials & Components Chart

PharmaCorp Rx Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
0.00 0.00 0.00 0.04 0.05

PharmaCorp Rx Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.05 0.05 0.06
TSXV:PCRX
35GF Score
PharmaCorp Rx Inc TSXV:PCRX
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PharmaCorp Rx Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of C$0.06 Mil mean?
PharmaCorp Rx (TSXV:PCRX) has a Inventories, Raw Materials & Components of C$0.06 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on PharmaCorp Rx and its competitors.
Is PharmaCorp Rx's Inventories, Raw Materials & Components too high?
PharmaCorp Rx's current Inventories, Raw Materials & Components is C$0.06 Mil. Overall, PharmaCorp Rx has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does PharmaCorp Rx's Inventories, Raw Materials & Components compare to competitors?
PharmaCorp Rx's Inventories, Raw Materials & Components of C$0.06 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Healthcare Providers & Services company?
A good Inventories, Raw Materials & Components depends on the Healthcare Providers & Services industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on PharmaCorp Rx and its competitors. PharmaCorp Rx's current Inventories, Raw Materials & Components is C$0.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaCorp Rx stock overvalued right now?
PharmaCorp Rx (TSXV:PCRX) has a current Inventories, Raw Materials & Components of C$0.06 Mil. The current Inventories, Raw Materials & Components is C$0.06 Mil. PharmaCorp Rx's overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For PharmaCorp Rx (TSXV:PCRX), the current Inventories, Raw Materials & Components is C$0.06 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaCorp Rx Business Description

Address 303 Wellman Lane, Suite 203, Saskatoon, SK, CAN, S7T 0J1
PharmaCorp Rx Inc operates three PharmaChoice bannered pharmacies in Canada and will continue to acquire PharmaChoice Canada-branded pharmacies as it come to market in conjunction with its strategic alliance agreement with PharmaChoice Canada. The company will also acquire independently owned non-PharmaChoice Canada-bannered pharmacies in Canada, and thereafter, continue to operate such acquired pharmacies under a PharmaChoice Canada banner.
35GF Score

Get the complete analysis for TSXV:PCRX

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.50
Price